
 
 
 
 
 
 
 
 
 Claims 
 
 1. A compound of formula (I) 
 
 
 
 wherein R is a substituted alkyl, benzyl or allyl residue selected from the group consisting of nonyl; 4,4,4-trifluoro-propyl; 2-methyl-4-phenyl-butyl; 4- trifluoromethyl-phenyl; pentafluorophenyl; 4-halo-phenyl, wherein halo is F or Br; naphthalene-2-yl; biphenyl-2-yl, biphenyl-3-yl, or biphenyl-4-yl; 4-tert- butyl-phenyl; 5,5,7,8,8-pentamethyl-5,6,7,8-tetrahydro-naphthalene-2-yl; 5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl; 1,1,3,3-tetramethyl- indan-5-yl; styryl; 2,6-dimethyl-hept-l,5-dienyl; 2-(4-tert-Butyl-phenyl)-l- methyl-vinyl; 2-(4-Isopropyl-phenyl)-l -methyl-vinyl; l-Methyl-3-(2,2,3- trimethyl-cyclopent-3-enyl)-propenyl; 2-(4-Isobutyl-phenyl)- 1 -methyl-vinyl; 2- (2-isopropyl-phenyl)-l-methyl-ethenyl; 2-phenyl-ethyl; cyclohexyl-methyl; 2,2- dimethyl-propyl; 2-pentafluorophenyl-ethyl; 3-phenyl-propyl; heptyl; and 4- isopropyl-cyclohex-1-enyl. 
 
 
 2. A composition comprising a body odour-suppressing quantity of a compound claimed in claim 1. 
 
 
 3. Composition according to claim 2 wherein the compound is present in amounts of about 0.01 to 0.5 % by weight. 
 
 
 4. Composition according to claim 2 or claim 3 selected from cosmetic and personal care products, in particular deo-sticks, roll-ons, pump-sprays, aerosols, deodorant soaps, powders, solutions, gels, creams, sticks, balms and lotions.   
 
 
 5. Use of a compound as defined by claim 1 or composition comprising a compound as defined by claim 1 to inhibit an enzyme in its ability to cleave compounds contained in sweat into short-chained, branched fatty acids, which enzyme is produced in bacteria of the genus Cotynebacteria, which bacteria has been deposited at the International Depository Authority DSMZ- Deutsche Sammlung von Mikrooganismen und Zellkulturen GmbH, D-38124 Braunschweig under the Accession Number DSM 14267. 
 
 
 6. Use of a compound as defined by claim 1 or composition comprising a compound as defined by claim 1 to inhibit an enzyme in its ability to cleave compounds contained in sweat into short-chained, branched fatty acids, which enzyme is defined by an amino acid sequence set forth as SEQ ID No. 1. 
 
 
 7. A method of suppressing axillary malodour comprising the step of providing a composition for application to a person in need of treatment, said composition containing an inhibitor compound and a dermatologically acceptable vehicle therefore, said compound being selected from one or more compound as defined by claim 1.  
 
 
 
 
 
 
 
 
 
 
